ARCT Arcturus Therapeutics, Inc.
$9.36
Arcturus Therapeutics, Inc. (ARCT) Earnings News
Earnings press releases, previews and reviews for Arcturus Therapeutics, Inc. (ARCT), newest first. Our most recent is review: Arcturus Beats on a One-Time CSL Windfall, but the Real Story Is a Bigger Pipeline With Later Decision Points.
Thursday
November 5, 2026
6:46 PM ET
Arcturus Beats on a One-Time CSL Windfall, but the Real Story Is a Bigger Pipeline With Later Decision Points
Earnings Whispers · Review
Thursday
November 5, 2026
4:01 PM ET
Arcturus Therapeutics Announces Third Quarter 2026 Financial Results and Pipeline Progress
Wednesday
October 28, 2026
6:21 PM ET
Arcturus Heads Into Q3 With OTC Data Window Closed and a Rallied Stock Awaiting Proof
Earnings Whispers · Preview
Monday
October 26, 2026
4:01 PM ET
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 5, 2026
Thursday
August 6, 2026
4:01 PM ET
Arcturus Therapeutics Announces Second Quarter 2026 Financial Results and Pipeline Progress
Tuesday
July 28, 2026
4:01 PM ET
Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on Aug 6, 2026